Regenxbio

Filed a patent for "treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids) produced by human neural or glial cells" on Thu, February 16, 2023

Filed a patent for "exon skipping gene therapy constructs and uses thereof" on Wed, March 15, 2023

Filed a patent for "exon skipping gene therapy constructs and uses thereof" on Thu, March 16, 2023

Filed a patent for "compositions and methods for recombinant aav production" on Fri, April 7, 2023

Filed a patent for "targeting aav capsids, methods of manufacturing and using same" on Thu, April 13, 2023

Filed a patent for "compositions and methods for recombinant aav production" on Sun, May 7, 2023

Filed a patent for "adeno-associated viruses for ocular delivery of gene therapy" on Tue, May 16, 2023

Filed a patent for "vectorized anti-complement antibodies and complement agents and administration thereof" on Tue, May 16, 2023

Filed a patent for "targeting aav capsids, methods of manufacturing and using same" on Tue, May 16, 2023

Filed a patent for "vectorized c5 inhibitor agents and administration thereof" on Tue, May 16, 2023

Filed a patent for "exon skipping gene therapy constructs and uses thereof" on Tue, May 16, 2023

Filed a patent for "exon skipping gene therapy constructs and uses thereof" on Mon, August 21, 2023

Filed a patent for "targeting aav capsids, methods of manufacturing and using same" on Mon, October 23, 2023

Filed a patent for "exon skipping gene therapy constructs, vectors and uses thereof" on Mon, October 23, 2023

Filed a patent for "vectorized anti-complement antibodies and complement agents and administration thereof" on Wed, November 8, 2023

Filed a patent for "exon skipping gene therapy constructs, vectors and uses thereof" on Tue, January 16, 2024

Filed a patent for "vectorized anti-complement antibodies and complement agents and administration thereof" on Mon, April 8, 2024

Filed a patent for "vectorized anti-complement antibodies and complement agents and administration thereof" on Mon, May 6, 2024

Filed a patent for "engineered nucleic acid regulatory elements and methods and uses thereof" on Thu, April 25, 2024

Filed a patent for "antibodies and methods of using thereof" on Fri, April 12, 2024

Filed a patent for "methods and compositions for treating epilepsy" on Wed, November 8, 2023

Filed a patent for "recombinant adeno-associated viruses for cns tropic delivery" on Tue, April 2, 2024

Filed a patent for "auf1 combination therapies for treatment of muscle degenerative disease" on Wed, January 17, 2024

Filed a patent for "recombinant adeno-associated viruses for targeted delivery" on Tue, April 2, 2024

Filed a patent for "vectorized tnf-alpha antagonists for ocular indications" on Wed, April 26, 2023